| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_726a3d235d237e2ead5f6fc692e40db0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-335 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 |
| filingDate |
2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c662ac9b240cc79c3a7ec3b8dde7f8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23d2deeda122d687f09805b18bba9b42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94b0cae74034e1afe09c325135cb7f6d |
| publicationDate |
2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7566701-B2 |
| titleOfInvention |
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
| abstract |
The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to von Willebrand Factor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10421798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9072665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009149643-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11060094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7998940-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9687529-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11192936-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11565002-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012264815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8790924-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085773-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10660973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11370827-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841429-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9873727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10889816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091534-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10138291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11685771-B2 |
| priorityDate |
2004-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |